Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions [Yahoo! Finance]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Yahoo! Finance
Capital Deployment: Approximately $2.6 billion year-to-date. Share Repurchase: $95 million repurchased in the third quarter, totaling $180 million for the first nine months of 2024. Full Year 2024 Guidance: Portfolio receipts expected between $2.75 billion and $2.8 billion. Expected Royalty Receipts Growth: 11% to 13% for the full year 2024. Operating Professional Costs: 7.5% of portfolio receipts in the third quarter. Net Interest Paid: $62 million in the third quarter. Portfolio Cash Flow: $617 million in the third quarter, with a margin of around 84%. Cash and Equivalents: $950 million at the end of the third quarter. Investment-Grade Debt: $7.8 billion outstanding with a weighted average cost of 3.1%. Leverage Ratio: Approximately 3 times total debt to adjusted EBITDA. Undrawn Financial Capacity: $1.8 billion revolver. Raised Full Year 2024 Guidance: Portfolio receipts expected to be in the range of $2.75 billion to $2.8 billion. Interest Paid for Full Yea
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Looking For Yields: Comcast, Royalty Pharma And Regions Financial Are Consistent Moneymakers [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at TD Cowen to a "strong-buy" rating.MarketBeat
- Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company [Yahoo! Finance]Yahoo! Finance
- Lightning Round: M&T Bank is a buy, I like the banks, says Jim Cramer [CNBC]CNBC
- 3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or Longer [Yahoo! Finance]Yahoo! Finance
RPRX
Sec Filings
- 1/2/25 - Form 4
- 1/2/25 - Form 4
- 12/31/24 - Form 8-K
- RPRX's page on the SEC website